You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
小智港股覆盤 | 12月10日

今日,港股三大指數集體下跌。截止收盤,恆生指數跌1.07%,報23995點。國企指數跌0.92%,報8578點。恆生科技指數跌1.11%,報6035點。市場約527只個股上漲,1116只個股下跌。成交額突破1138.83億港幣,和昨天同期相比下跌9.03%。南下資金淨流入28.88億港幣。

領跌板塊

盤面上,媒體板塊走高。皓天財經集團漲超6%;文化傳信、閱文集團等多股漲超5%;中視金橋、中播控股等多股漲超2%。皓天財經:以4454.55萬港元)購入合共6萬股騰訊股份;大摩相信閱文集團未來15日股價將上升。

板塊行情

食品零售板塊活躍。亨泰漲超19%;香港食品投資漲超6%;COOL LINK漲超5%;萬隆控股集團、利特米等多股漲超1%。亨泰12月9日完成發行2.29億股代價股份。

板塊行情

CRO板塊跌幅居前。方達控股跌超7%;維亞生物、泰格醫藥等多股跌超5%;藥明生物跌超4%;中國醫療集團跌超3%。小摩增持泰格醫藥18.37萬股,每股作價約124.84港元;大摩相信藥明生物股價30日內將升,評級「增持」目標價175元。

板塊行情

互聯網醫療板塊跌幅較前。阿裏健康、平安好醫生等多股跌超4%;醫脈通跌超3%。廣發證券:維持平安好醫生“買入”評級,目標價51.8港元。

板塊行情

生物科技板塊跌幅居前。中國再生醫學跌超9%;百濟神州跌超5%;創勝集團-B、嘉和生物-B、雲頂新耀-B等多股跌超4%。嘉和生物-B因受限制股份單位獲歸屬而發行4500股。

板塊行情

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account